GlaxoSmithKline Consumer Healthcare rises on inking pact with GSK Pharmaceuticals

07 May 2013 Evaluate

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 4053.00, up by 11.40 points or 0.28 % from its previous closing of Rs. 4041.60 on the BSE.

The scrip opened at Rs. 4035.00 and has touched a high and low of Rs. 4080.10 and Rs. 4025.10 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4334.00 on 22-Feb-2013 and a 52 week low of Rs. 2179.00 on 18-Jul-2012.

Last one week high and low of the scrip stood at Rs. 4260.00 and Rs. 3810.05 respectively. The current market cap of the company is Rs. 17074.55 crore.

The promoters holding in the company stood at 72.46% while Institutions and Non-Institutions held 11.86% and 15.69% respectively.

GlaxoSmithKline Consumer Healthcare has signed a brandsswap deal with its associate company GSK Pharmaceuticals, in order to cross Rs 8,000-crore revenue mark by 2016. With this brandsswap deal, the entity can select brands and independently market, sell and distribute them. With this initiative, both the firms can increase distribution pooling in their resources.

Initially, it will market and sell GSK Pharma's over-the counter calcium and vitamin supplement Ostocalcium while GSK Pharma will market and distribute products under the consumer division’s specialized arm Glaxo Nutrition including Actibase and Actigrow nutrition supplements. The deals will involve a cost that both the listed entities will pay each other.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 2509.65
Britannia Inds 4790.75
Varun Beverages 1481.20
Marico 515.80
Hatsun Agro Product 1079.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.